We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax Labs Settles Portion of Solodyn Pay-for-Delay Cases for $35 Million, as Trial Begins
Impax Labs Settles Portion of Solodyn Pay-for-Delay Cases for $35 Million, as Trial Begins
Generic manufacturer Impax Laboratories agreed to pay $35 million to settle pay-for-delay lawsuits brought by a class of direct purchasers of the acne medication Solodyn (minocycline), sold by Medicis Pharmaceutical, a unit of Valeant.